BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30426827)

  • 1. Vemurafenib-induced histiocytoid neutrophilic panniculitis simulating myeloid leukaemia cutis.
    Richarz NA; Puig L; Pérez N; Cuadra-Urteaga J; Elez E; Fernández-Figueras MT
    Cancer Biol Ther; 2019; 20(3):237-239. PubMed ID: 30426827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histiocytoid neutrophilic dermatoses and panniculitides: variations on a theme.
    Chow S; Pasternak S; Green P; Tremaine R; Reardon M; Murray S; Northgrave S; Walsh N
    Am J Dermatopathol; 2007 Aug; 29(4):334-41. PubMed ID: 17667165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophilic panniculitis with vasculitis in a melanoma patient treated with vemurafenib: a case report and its management.
    Ueno M; Namiki T; Inui K; Hanafusa T; Miura K; Yokozeki H
    Int J Dermatol; 2017 Aug; 56(8):e163-e165. PubMed ID: 28244062
    [No Abstract]   [Full Text] [Related]  

  • 4. Sweet's syndrome--like neutrophilic lobular panniculitis associated with all-trans-retinoic acid chemotherapy in a patient with acute promyelocytic leukemia.
    Jagdeo J; Campbell R; Long T; Muglia J; Telang G; Robinson-Bostom L
    J Am Acad Dermatol; 2007 Apr; 56(4):690-3. PubMed ID: 17367621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vemurafenib-induced neutrophilic panniculitis in a child with a brainstem glioma.
    West ES; Williams VL; Morelli JG
    Pediatr Dermatol; 2015; 32(1):153-4. PubMed ID: 24602192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vemurafenib-Induced Neutrophilic Panniculitis: A New Case and Review of the Literature.
    Vázquez-Osorio I; Sánchez-Aguilar MD; García-Rodiño S; Suárez-Peñaranda JM; Aliste C; Vázquez-Veiga H
    Am J Dermatopathol; 2016 Jul; 38(7):e93-6. PubMed ID: 26959695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lesiones subcutáneas dolorosas en paciente con melanoma metastásico: un caso de paniculitis linfocítica asociado a vemurafenib.
    Benavente-Villegas F; Ferrando-Roca F; Dolz-Gaitón R; Royo-Peiró M
    Dermatol Online J; 2017 Oct; 23(10):. PubMed ID: 29469793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vemurafenib-induced neutrophilic panniculitis.
    Monfort JB; Pagès C; Schneider P; Neyns B; Comte C; Bagot M; Vignon-Pennamen MD; Viguier M; Lebbé C
    Melanoma Res; 2012 Oct; 22(5):399-401. PubMed ID: 22828248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vemurafenib-associated neutrophilic panniculitis: An emergent adverse effect of variable severity.
    Maldonado-Seral C; Berros-Fombella JP; Vivanco-Allende B; Coto-Segura P; Vazquez-Lopez F; Perez-Oliva N
    Dermatol Online J; 2013 Apr; 19(4):16. PubMed ID: 24021375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous histiocytoid Sweet's syndrome in a patient with myelodysplastic syndrome and acute myeloblastic leukemia.
    Srisuttiyakorn C; Reeve J; Reddy S; Imaeda S; Lazova R
    J Cutan Pathol; 2014 May; 41(5):475-9. PubMed ID: 24877196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Panniculitis With Necrotizing Granulomata in a Patient on BRAF Inhibitor (Dabrafenib) Therapy for Metastatic Melanoma.
    Ramani NS; Curry JL; Kapil J; Rapini RP; Tetzlaff MT; Prieto VG; Torres-Cabala CA
    Am J Dermatopathol; 2015 Aug; 37(8):e96-9. PubMed ID: 25839886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sweet's syndrome with subcutaneous involvement associated with pegfilgrastim treatment: first reported case.
    Llamas-Velasco M; García-Martín P; Sánchez-Pérez J; Fraga J; García-Diez A
    J Cutan Pathol; 2013 Jan; 40(1):46-9. PubMed ID: 23131080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recurrent neutrophilic panniculitis in a patient with chronic myelogenous leukaemia treated with imatinib mesilate and dasatinib].
    de Masson A; Bouvresse S; Clérici T; Mahé E; Saïag P
    Ann Dermatol Venereol; 2011 Feb; 138(2):135-9. PubMed ID: 21333826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophilic panniculitis developing after treatment of metastatic melanoma with vemurafenib.
    Kim GH; Levy A; Compoginis G
    J Cutan Pathol; 2013 Jul; 40(7):667-9. PubMed ID: 23581649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Panniculitis in patients treated with BRAF inhibitors: a case series.
    Choy B; Chou S; Anforth R; Fernández-Peñas P
    Am J Dermatopathol; 2014 Jun; 36(6):493-7. PubMed ID: 24879511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Panniculitis with arthralgia in patients with melanoma treated with selective BRAF inhibitors and its management.
    Zimmer L; Livingstone E; Hillen U; Dömkes S; Becker A; Schadendorf D
    Arch Dermatol; 2012 Mar; 148(3):357-61. PubMed ID: 22250191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two neutrophilic dermatoses captured simultaneously on histology.
    Wlodek C; Bhatt N; Kennedy C
    Dermatol Pract Concept; 2016 Jul; 6(3):55-7. PubMed ID: 27648385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-limiting Ibrutinib-Induced Neutrophilic Panniculitis.
    Stewart J; Bayers S; Vandergriff T
    Am J Dermatopathol; 2018 Feb; 40(2):e28-e29. PubMed ID: 28953011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lobular neutrophilic panniculitis associated with DNA methyltransferase inhibitors in the treatment of myeloid disease.
    Coleman E; Panse G; Cowper S; Prebet T; Gore S; Leventhal J
    J Cutan Pathol; 2019 Dec; 46(12):930-934. PubMed ID: 31254406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic myeloid leukemia-leukemia cutis mimicking a neutrophilic panniculitis-like leukemia cutis: Report of a rare case.
    Zelman B; Bode-Omoleye O; Muhlbauer A; Agidi A; Mafee M; Velankar M; Mirza K; Speiser J; Mudaliar K
    J Cutan Pathol; 2021 Oct; 48(10):1277-1281. PubMed ID: 33891722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.